PGIM India Mutual Fund has launched a new fund offer (NFO), PGIM India Healthcare Fund. This is a thematic fund which will invest in pharmaceuticals and healthcare / healthcare related stocks. Healthcare is a popular investment theme and has strong growth prospects as India’s economy continues to grow. The NFO has opened for subscription on 19th November 2024 and will close on 3rd December 2024. In this article we will review, PGIM India Healthcare Fund.
Source: AMSEC, MOSPI/ Press Information Bureau, U.S. Bureau of Labour Statistics, National Bureau of Statistics of China, Bank Indonesia, Red seer analysis, WHO. NCD- Non communicable disease (lifestyle diseases such as diabetes), WHO Global Health Expenditure Database accessed in October 2024 (2021 Data) *Data as of 31-Mar-23
Source: MFI ICRA, PGIM India Internal Data. Data as on 31st August 2004 to 31st October 2024. It should not be construed to be indicative of scheme performance in any manner. Past performance may or may not be sustained in the future.
Source: MFI ICRA, PGIM India Internal Data. Data as of 30-Sep-24
Source: CRISIL MI&A, Frost & Sullivan, Department of Pharmaceuticals, Dun and Bradstreet estimates, IQVIA. API- Active Pharmaceutical Ingredient, CDMOs- Contract development and manufacturing organizations, OPD-Outpatient, IPD- Inpatient, CRO- Contract research organizations. Taken 84.43 as the USD INR conversion rate. Data as of FY 2024. The above-mentioned numbers are approximate estimates
Source: Factset, PGIM India Internal Analysis. For understanding purposes only. The sub-segments are the internal bifurcation of PGIM India AMC. The stock(s) mentioned in this slide do not constitute any recommendation and PGIM India Mutual Fund may or may not have any future position in this stock(s) Past performance may or may not be sustained in the future and is not a guarantee of any future returns. Index performance does not signify scheme performance. CDMOs- Contract development and manufacturing organizations, CRO- Contract research organizations.
Investors should consult with their financial advisors or mutual fund distributors if PGIM India Healthcare Fund is suitable for their investment needs.
Mutual Fund Investments are subject to market risk, read all scheme related documents carefully.
PGIM is the global investment management business of Prudential Financial, Inc. (PFI) USA, with USD 1.5 trillion1 in assets under management. We offer a broad range of investment capabilities through our multi-manager model along with experienced investment teams that assist you in achieving your financial goals. With a glorious legacy of 145 years, PGIM is built on the strength, stability and deep expertise in managing money. We offer you a long-term perspective, having weathered multiple market cycles, and see opportunity in periods of disruption.